Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    B2B2C/B2G/B2B, In Clinical Trial stage, Multiple funding stages, Small/Large, Drugs Discovery & Development Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (3)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (3)

    Product Stage (1)

    Employees (2)

    Location 

    Status 

    8 Startups 0 In the News 1 Recently Updated
    • Total Funding
      $331.82M
      Raised
      28
      Events
    • Private Funding
      $174.02M
      Raised
      19
      Rounds
    • Public Offerings
      $157.8M
      Raised
      7
      Offerings
    • M&A
      $0
      Raised
      2
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    ELGAN Pharma logo

    ELGAN Pharma

    Neonatal Therapies
    2018 B2B 11-50 A $7.5M
    biopharmaceutical
    visually-impaired
    biotechnology
    nanotechnology
    medical-technologies
    treatments
    eye-diseases
    Biomica logo

    Biomica

    Microbiome-based Therapeutics
    2017 B2B 11-50 A $0
    oncology
    medical-technologies
    bacteria
    gastroenterology
    therapeutics
    biotechnology
    microbiome
    biopharmaceutical
    cancer
    pharma-companies
    immuno-theraphy
    Cellect Biotechnology logo

    Cellect Biotechnology

    Acquired
    Immune System Regeneration
    2011 B2B 11-50 Mature $24.26M
    therapeutics
    immunology
    regenerative-medicine
    cell-therapy
    bioprocess
    biotechnology
    medical-technologies
    stem-cells
    chronic-patients
    cancer
    medical-devices
    academia
    cancer-therapy
    diabetes
    pharma-companies
    laboratories
    healthcare-providers
    Chiasma logo

    Chiasma

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Oral Therapeutic Options for Patients with Rare Diseases
    2001 B2B 11-50 Mature $293.7M
    drug-delivery
    oral-drugs
    biopharmaceutical
    pharmaceuticals
    drug-development
    rare-diseases
    pharma-companies
    nanotechnology
    chronic-disease
    Mapi Pharma logo

    Mapi Pharma

    Lifecycle Management for Pharmaceuticals
    2008 B2B 11-50 A $42.5M
    pain-relief
    pharmaceuticals
    diabetes
    generic-drugs
    epilepsy
    schizophrenia
    inflammatory-diseases
    pharma-companies
    MyBiotics Pharma logo

    MyBiotics Pharma

    Clinically Effective Microbiome and Probiotic Products
    2014 B2B, B2C 11-50 A $11.27M
    bacteria
    supplements
    gastroenterology
    drug-delivery
    oncology
    cancer
    microbiome
    pharmaceuticals
    pharma-companies
    cosmetics
    dermatology
    nutrition
    artificial-intelligence
    life-sciences
    therapeutics
    skin-care
    patients
    women-health
    wellness
    drug-development
    consumers
    personalization
    biotechnology
    bioconvergence
    Nectin Therapeutics logo

    Nectin Therapeutics

    Next-generation Immunotherapy Agents
    2017 B2B 11-50 A $36M
    biotechnology
    pharmaceuticals
    oncology
    immunology
    cancer-therapy
    cancer
    antibodies
    patients
    drug-delivery
    treatments

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    8 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $331.82M
      Raised
      28
      Events
    • Private Funding
      $174.02M
      Raised
      19
      Rounds
    • Public Offerings
      $157.8M
      Raised
      7
      Offerings
    • M&A
      $0
      Raised
      2
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    ELGAN Pharma logo
    Raised
    $7.5M
    ELGAN Pharma
    Neonatal Therapies
    Founded:2018
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    Biomica logo
    Raised
    $0
    Biomica
    Microbiome-based Therapeutics
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    Cellect Biotechnology logo
    Raised
    $24.26M
    Cellect Biotechnology
    Acquired
    Immune System Regeneration
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Chiasma logo
    Raised
    $293.7M
    Chiasma
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Oral Therapeutic Options for Patients with Rare Diseases
    Founded:2001
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Mapi Pharma logo
    Raised
    $42.5M
    Mapi Pharma
    Lifecycle Management for Pharmaceuticals
    Founded:2008
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    MyBiotics Pharma logo
    Raised
    $11.27M
    MyBiotics Pharma
    Clinically Effective Microbiome and Probiotic Products
    Founded:2014
    Business Model:B2B, B2C
    Employees:11-50
    Funding Stage:A
    Nectin Therapeutics logo
    Raised
    $36M
    Nectin Therapeutics
    Next-generation Immunotherapy Agents
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,